Literature DB >> 32882164

A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance.

Kun Lyu1, Ye Zhang2, Dongyan Zhang3, Mario Kahn3, Kasper W Ter Horst4, Marcos R S Rodrigues5, Rafael C Gaspar6, Sandro M Hirabara7, Panu K Luukkonen3, Seohyuk Lee3, Sanjay Bhanot8, Jesse Rinehart9, Niels Blume10, Morten Grønbech Rasch11, Mireille J Serlie4, Jonathan S Bogan12, Gary W Cline3, Varman T Samuel13, Gerald I Shulman14.   

Abstract

Nonalcoholic fatty liver disease is strongly associated with hepatic insulin resistance (HIR); however, the key lipid species and molecular mechanisms linking these conditions are widely debated. We developed a subcellular fractionation method to quantify diacylglycerol (DAG) stereoisomers and ceramides in the endoplasmic reticulum (ER), mitochondria, plasma membrane (PM), lipid droplets, and cytosol. Acute knockdown (KD) of diacylglycerol acyltransferase-2 in liver induced HIR in rats. This was due to PM sn-1,2-DAG accumulation, which promoted PKCϵ activation and insulin receptor kinase (IRK)-T1160 phosphorylation, resulting in decreased IRK-Y1162 phosphorylation. Liver PM sn-1,2-DAG content and IRK-T1160 phosphorylation were also higher in humans with HIR. In rats, liver-specific PKCϵ KD ameliorated high-fat diet-induced HIR by lowering IRK-T1160 phosphorylation, while liver-specific overexpression of constitutively active PKCϵ-induced HIR by promoting IRK-T1160 phosphorylation. These data identify PM sn-1,2-DAGs as the key pool of lipids that activate PKCϵ and that hepatic PKCϵ is both necessary and sufficient in mediating HIR.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ceramides; dicylglycerols; hepatic glucose production; hepatic glycogen synthesis; hepatic insulin resistance; insulin receptor phosphorylation; liquid chromatography-tandem mass spectrometry; nonalcoholic fatty liver disease; protein kinase C-epsilon; type 2 diabetes

Year:  2020        PMID: 32882164      PMCID: PMC7544641          DOI: 10.1016/j.cmet.2020.08.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  45 in total

Review 1.  Purification of organelles from mammalian cells.

Authors:  J David Castle
Journal:  Curr Protoc Immunol       Date:  2003-11

Review 2.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

Review 3.  The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

4.  The stereospecific activation of protein kinase C.

Authors:  R R Rando; N Young
Journal:  Biochem Biophys Res Commun       Date:  1984-07-31       Impact factor: 3.575

5.  Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice.

Authors:  Kaori Minehira; Stephen G Young; Claudio J Villanueva; Laxman Yetukuri; Matej Oresic; Mark K Hellerstein; Robert V Farese; Jay D Horton; Frederic Preitner; Bernard Thorens; Luc Tappy
Journal:  J Lipid Res       Date:  2008-06-01       Impact factor: 5.922

6.  Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.

Authors:  Cheol Soo Choi; David B Savage; Ameya Kulkarni; Xing Xian Yu; Zhen-Xiang Liu; Katsutaro Morino; Sheene Kim; Alberto Distefano; Varman T Samuel; Susanne Neschen; Dongyan Zhang; Amy Wang; Xian-Man Zhang; Mario Kahn; Gary W Cline; Sanjay K Pandey; John G Geisler; Sanjay Bhanot; Brett P Monia; Gerald I Shulman
Journal:  J Biol Chem       Date:  2007-05-27       Impact factor: 5.157

7.  The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance.

Authors:  Robert V Farese; Rudolf Zechner; Christopher B Newgard; Tobias C Walther
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

8.  Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes.

Authors:  Rachel J Perry; Liang Peng; Gary W Cline; Yongliang Wang; Aviva Rabin-Court; Joongyu D Song; Dongyan Zhang; Xian-Man Zhang; Yuichi Nozaki; Sylvie Dufour; Kitt Falk Petersen; Gerald I Shulman
Journal:  Cell Metab       Date:  2017-11-09       Impact factor: 27.287

9.  Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans.

Authors:  Kasper W Ter Horst; Pim W Gilijamse; Ruth I Versteeg; Mariette T Ackermans; Aart J Nederveen; Susanne E la Fleur; Johannes A Romijn; Max Nieuwdorp; Dongyan Zhang; Varman T Samuel; Daniel F Vatner; Kitt F Petersen; Gerald I Shulman; Mireille J Serlie
Journal:  Cell Rep       Date:  2017-06-06       Impact factor: 9.423

10.  Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration.

Authors:  Zheng Sun; Russell A Miller; Rajesh T Patel; Jie Chen; Ravindra Dhir; Hong Wang; Dongyan Zhang; Mark J Graham; Terry G Unterman; Gerald I Shulman; Carole Sztalryd; Michael J Bennett; Rexford S Ahima; Morris J Birnbaum; Mitchell A Lazar
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

View more
  24 in total

Review 1.  Contribution of specific ceramides to obesity-associated metabolic diseases.

Authors:  Philipp Hammerschmidt; Jens C Brüning
Journal:  Cell Mol Life Sci       Date:  2022-07-05       Impact factor: 9.207

Review 2.  Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue.

Authors:  Maria Petrescu; Sonia Irina Vlaicu; Lorena Ciumărnean; Mircea Vasile Milaciu; Codruța Mărginean; Mira Florea; Ștefan Cristian Vesa; Monica Popa
Journal:  Medicina (Kaunas)       Date:  2022-05-06       Impact factor: 2.948

3.  Chronic Jetlag Alters the Landscape of the Pancreatic Lipidome.

Authors:  Patrick B Schwartz; Gregory A Barrett-Wilt; Sean M Ronnekleiv-Kelly
Journal:  Pancreas       Date:  2022-01-01       Impact factor: 3.243

4.  Bioactive lipids and metabolic syndrome-a symposium report.

Authors:  Loren M DeVito; Edward A Dennis; Barbara B Kahn; Gerald I Shulman; Joseph L Witztum; Sudeshna Sadhu; Joseph Nickels; Matthew Spite; Susan Smyth; Sarah Spiegel
Journal:  Ann N Y Acad Sci       Date:  2022-02-25       Impact factor: 6.499

5.  Reducing lipid bilayer stress by monounsaturated fatty acids protects renal proximal tubules in diabetes.

Authors:  Albert Pérez-Martí; Suresh Ramakrishnan; Jiayi Li; Aurelien Dugourd; Martijn R Molenaar; Luigi R De La Motte; Kelli Grand; Anis Mansouri; Mélanie Parisot; Soeren S Lienkamp; Julio Saez-Rodriguez; Matias Simons
Journal:  Elife       Date:  2022-05-12       Impact factor: 8.713

Review 6.  The aetiology and molecular landscape of insulin resistance.

Authors:  David E James; Jacqueline Stöckli; Morris J Birnbaum
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-20       Impact factor: 94.444

Review 7.  Defining the underlying defect in insulin action in type 2 diabetes.

Authors:  Thiago M Batista; Nida Haider; C Ronald Kahn
Journal:  Diabetologia       Date:  2021-03-17       Impact factor: 10.122

8.  Lysophospholipid acylation modulates plasma membrane lipid organization and insulin sensitivity in skeletal muscle.

Authors:  Patrick J Ferrara; Xin Rong; J Alan Maschek; Anthony Rp Verkerke; Piyarat Siripoksup; Haowei Song; Thomas D Green; Karthickeyan C Krishnan; Jordan M Johnson; John Turk; Joseph A Houmard; Aldons J Lusis; Micah J Drummond; Joseph M McClung; James E Cox; Saame Raza Shaikh; Peter Tontonoz; William L Holland; Katsuhiko Funai
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 19.456

9.  Short-term overnutrition induces white adipose tissue insulin resistance through sn-1,2-diacylglycerol/PKCε/insulin receptor Thr1160 phosphorylation.

Authors:  Kun Lyu; Dongyan Zhang; Joongyu Song; Xiruo Li; Rachel J Perry; Varman T Samuel; Gerald I Shulman
Journal:  JCI Insight       Date:  2021-02-22

Review 10.  Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH.

Authors:  Leigh Goedeke; Gerald I Shulman
Journal:  Mol Metab       Date:  2021-02-03       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.